Juvenile Diabetes Research Foundation DE

Juvenile Diabetes Research Foundation DE

Juvenile Diabetes Research Foundation DE
Juvenile Diabetes Research Foundation DE
Receive news and event information.
Donate directly to our organization.
Connect with this organization

*For Organizations Only*


Curing Type 1 Diabetes (T1D) Improving Lives

JDRF offer fellowships and grants designed to attract the best and brightest to the field of T1D research.

JDRF is the world’s biggest nonprofit funder of type 1 diabetes (T1D) research. Our focus is on finding a cure; until we do, the advancements we’re making every day ease the burden of those living with the disease.

Curing T1D

Our research has two core objectives: curing T1D by helping the body’s inability to control glucose, reversing insulin dependence and prevent the progression of the disease in those at risk or recently diagnosed; and improving lives by treating people living with T1D with new drugs, therapies and devices that make it easier to stay healthy until the cure comes.

Improving Lives

At JDRF, we are driving research forward in two core areas: curing type 1 diabetes and improving the lives of the people burdened by this disease today.

As members of the T1D Community, we understand the struggles and stress that come with this disease. We know T1D must be shouldered every minute of every day. The challenges to living a healthy and long life are very real.
Category: Family Shade Member
Our Approach

People are being diagnosed with T1D at a growing rate. T1D is not preventable, and there is no cure—yet. At JDRF, we have developed significant knowledge about the causes of T1D. As we increase our understanding of these causes, we will also uncover ways to prevent them from occurring. Until we have found ways to prevent T1D, we must stop or slow its progression during its earliest stages.


To eliminate the threat of type 1 diabetes (T1D) for future generations, the JDRF Prevention Program teams up with allies in academia, industry and government to fund groundbreaking research, and then translates this knowledge into therapies that can stop T1D from developing.